International regulation: the importance of quality assurance in drug development
European Pharmaceutical Review
JULY 4, 2023
Since the first ADC was approved by the EMA in 2012, they have generated a great deal of interest in the oncology field because of their potential to address many of the challenges of traditional chemotherapy options.
Let's personalize your content